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Abstract—The Na+/K+/Cl cotransporter-1 (NKCC1) and the K+/Cl cotransporter-2 (KCC2) set the transmem-
brane Cl gradient in the brain, and are implicated in epileptogenesis. We studied the postnatal distribution of
NKCC1 and KCC2 in wild-type (WT) mice, and in a mouse model of sleep-related epilepsy, carrying the mutant
b2-V287L subunit of the nicotinic acetylcholine receptor (nAChR). In WT neocortex, immunohistochemistry
showed a wide distribution of NKCC1 in neurons and astrocytes. At birth, KCC2 was localized in neuronal somata,
whereas at subsequent stages it was mainly found in the somatodendritic compartment. The cotransporters’
expression was quantified by densitometry in the transgenic strain. KCC2 expression increased during the first
postnatal weeks, while the NKCC1 amount remained stable, after birth. In mice expressing b2-V287L, the KCC2
amount in layer V of prefrontal cortex (PFC) was lower than in the control littermates at postnatal day 8 (P8), with
no concomitant change in NKCC1. Consistently, the GABAergic excitatory to inhibitory switch was delayed in
PFC layer V of mice carrying b2-V287L. At P60, the amount of KCC2 was instead higher in mice bearing the trans-
gene. Irrespective of genotype, NKCC1 and KCC2 were abundantly expressed in the neuropil of most thalamic
nuclei since birth. However, KCC2 expression decreased by P60 in the reticular nucleus, and more so in mice
expressing b2-V287L. Therefore, a complex regulatory interplay occurs between heteromeric nAChRs and
KCC2 in postnatal forebrain. The pathogenetic effect of b2-V287L may depend on altered KCC2 amounts in
PFC during synaptogenesis, as well as in mature thalamocortical circuits.  2018 IBRO. Published by Elsevier Ltd.
All rights reserved.Key words: ADNFLE, b2-V287L, GABAergic switch, KCC2, prefrontal cortex, reticular thalamic.INTRODUCTION
The Na+/K+/Cl cotransporter-1 (NKCC1) and the K+/
Cl cotransporter-2 (KCC2) are major regulators of the
intracellular Cl concentration ([Cl]i; Kaila et al.,https://doi.org/10.1016/j.neuroscience.2018.06.030
0306-4522/ 2018 IBRO. Published by Elsevier Ltd. All rights reserved.
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release produces depolarizing effects that modulate neu-
ronal maturation and synaptogenesis (Ben-Ari et al.,
2007; Cancedda et al., 2007). Around birth, KCC2
expression progressively increases. By lowering [Cl]i,
KCC2 leads EGABA to the typical hyperpolarized values
observed in the adult brain (Rivera et al., 1999; Kaila
et al., 2014a). In murine neocortex, such ‘GABAergic
switch’ occurs during the first two postnatal weeks. Being
concomitant with the formation of GABAergic synapses
(Takayama and Inoue, 2010), it is thought to regulate
the postnatal maturation of neuronal circuits (Ge et al.,
2006; Ben-Ari et al., 2007).
The balance of abundance and activity of NKCC1 and
KCC2 is implicated in epileptogenesis as well as in the
compensatory responses observed in hyperexcitable
networks (Khirug et al., 2010; Kaila et al., 2014b). In fact,
genetic variants of these cotransporters are linked to
human idiopathic epilepsy (Kahle et al., 2014; Puskarjov
et al., 2014). Epilepsy, however, comprises a heteroge-
neous spectrum of disorders (Jensen, 2011). The role of
NKCC1 and KCC2 has been extensively studied in pari-
etal and temporal lobe epilepsy (Dzhala et al., 2005;
Aronica et al., 2007; Pathak et al., 2007; Li et al., 2008;
Zhu et al., 2008; Talos et al., 2012; Awad et al., 2016;
Karlo´cai et al., 2016), but not in frontal epilepsy. The latter
presents distinct pathophysiological features, particularly
in relation to the sleep-waking cycle. In frontal lobe epi-
lepsy, sleep favors focal seizures, but not the occurrence
of secondary generalization. The opposite holds in the
focal epilepsies originating in other cortical regions
(Shouse and Quigg, 2008).
To address these issues, we focused on Autosomal
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE),
the mendelian form of hypermotor sleep-related
epilepsy, which is characterized by focal hyperkinetic
seizures mainly occurring during non-rapid-eye-
movement sleep (Tinuper et al., 2016). ADNFLE is fre-
quently caused by point mutations on genes coding for
a or b subunits of the neuronal nicotinic acetylcholine
receptor (nAChR; Tinuper et al., 2016). In the mammalian
neocortex, the most widespread heteromeric nAChR is
a4b2, and the first ADNFLE mutations identified on these
subunits were a4-S248F (Steinlein et al., 1995) and b2-
V287L (De Fusco et al., 2000). In heterologous expres-
sion systems, ADNFLE mutations often increase the
nAChR function, at least in the heterozygous state, by
augmenting its sensitivity to the agonists or causing other
kinetic alterations (Becchetti et al., 2015). Previous stud-
ies on the first conditional murine model of ADNFLE,
expressing b2-V287L in the brain under control of a tetra-
cycline promoter, suggest that the transgene could exert
its effects during synaptogenesis (Manfredi et al., 2009).
Mice carrying b2-V287L develop spontaneous epilepti-
form seizures, mostly occurring during periods of
increased delta electroencephalographic activity, which
is typical of slow-wave sleep. However, for the epileptic
phenotype to manifest, b2-V287L must be expressed
throughout brain development, until the end of the second
postnatal week (Manfredi et al., 2009). These
results agree with recent lines of evidence suggesting thatseveral nAChR subunits, including b2, display a peak of
expression between the second and third postnatal weeks
in neocortex and hippocampus (Mansvelder and Role,
2006; Molas and Dierssen, 2014). It has thus been sug-
gested that nAChRs regulate synaptogenesis, even
though the underlying cellular mechanisms are largely
unknown (Molas and Dierssen, 2014). Nonetheless, the
spontaneous nAChR activity affects the developmental
GABAergic switch in neuronal cultures (Liu et al., 2006).
In fact, both b2-containing nAChRs (Lozada et al.,
2012) and KCC2 (Li et al., 2007; Fiumelli et al., 2013;
Puskarjov et al., 2014) are involved in maturation and
remodeling of dendritic spines. Moreover, rats expressing
another nAChR mutation linked to ADNFLE (i.e., a4-
S284L) display an altered KCC2/NKCC1 messenger ratio
(Yamada et al., 2013). Hence, we hypothesized that an
early regulatory link might exist between b2-containing
nAChRs and the Cl cotransporters, which could have
long-term effects on neocortex circuits and excitability.
The timing of NKCC1 and KCC2 appearance in
neocortex and thalamus (TH) was previously studied in
rats (Clayton et al., 1998; Yan et al., 2001; Wang et al.,
2002; Bartho´ et al., 2004; Kova´cs et al., 2014), mice
(Hu¨bner et al., 2001; Stein et al., 2004; Takayama and
Inoue, 2010; Markkanen et al., 2014), and humans
(Hyde et al., 2011; Sedmak et al., 2016). However, no
detailed analysis is available in mouse for associative cor-
tices and TH nuclei, the most relevant regions for a sleep-
related frontal epilepsy. To investigate the interplay
between a4b2 nAChRs and the Cl/cation cotransporters,
we first determined the NKCC1 and KCC2 distribution in
developing neocortex and TH of wild-type (WT) mice.
Next, we studied if the amount of these cotransporters
was altered in mice expressing b2-V287L. The morpho-
logical analysis was coupled with a patch-clamp study of
EGABA time course in prefrontal cortex (PFC) layer V,
which is the most susceptible to develop epileptiform
activity (Telfeian and Connors, 1998). Our results show
that altering the function of b2-containing nAChRs affects
KCC2 expression during postnatal development, and sug-
gest that this mechanism may contribute to
epileptogenesis.EXPERIMENTAL PROCEDURES
Animals
Mice were kept in pathogen-free conditions, with a 12-h
light–dark cycle, and free access to water and food. All
procedures followed the Italian law (2014/26,
implementing the 2010/63/UE) and were approved by
the local Ethics Committees and the Italian Ministry of
Health. For the morphological analyses of WT mice, we
used 33 FVB mice (Harlan) of either sex, at the
following embryonic (E) or postnatal (P) days: E14–15
(n= 6), P0–2 (n= 8); P5 (n= 2); P7 (n= 4); P12–
P14 (n= 5); P19–21 (n= 3); P40–60 (n= 5). The
transgenic strain we used was the S3 line of double
transgenic FVB (tTA:Chrnb2V287L) mice, which express
b2-V287L under a tetracycline-controlled transcriptional
activator (tTA). These mice were compared with their
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WT or bearing TRE-Chrnb2V287L or PrnP-tTA
genotypes (Manfredi et al., 2009). For clarity, mice
expressing the transgene are hereafter denoted as
b2-V287L, while the control littermates are denoted as
controls (CTRL). The morphological analysis was carried
out on 14 animals of either sex for each experimental
group (CTRL and b2-V287L), at P8 (n= 6), P21
(n= 6), and P60 (n= 16). Patch-clamp recordings were
carried out on 15 CTRL (all PrnP-tTA) and 9 b2-V287L
mice, whose age distribution is detailed in the Results.
No morphological or electrophysiological difference was
observed between sexes.
Brain regions
For immunohistochemistry and densitometric analyses,
by PFC we refer to the entire secondary motor region
(also known as M2, or Fr2) in the dorsomedial shoulder
of prefrontal cortex. According to Franklin and Paxinos
(2008), coronal prefrontal sections were cut between
+2.58 and +1.14 mm from bregma. For somatosensory
cortex (SS), we sampled the extended SS region between
+1.98 and +0.02 mm from bregma. Thalamic sections
for reticular (RT) and ventrobasal (VB) nuclei were pre-
pared between 0.58 and 1.82 mm from bregma. For
patch-clamp experiments, coronal PFC (Fr2) slices were
cut between +2.68 mm and +2.10 mm from bregma.
Chemicals and drugs
Chemicals and drugs were purchased from Sigma–
Aldrich, except for D()-2-amino-5-phosphono-pentanoic
acid (AP5), 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX), and tetrodotoxin (TTX), which were purchased
from Tocris Bioscience (UK). Stock solutions of
gramicidin D (100 mg/ml) and CNQX (20 mM) were
prepared in dimethylsulfoxide. Stock solutions of GABA,
AP5, and TTX were prepared in distilled water, stored at
20 C, and diluted daily to the final concentration in
our extracellular solution.
Tissue preparation for immunohistochemistry
Postnatal mice were anesthetized with isoflurane and
intraperitoneal 4% chloral hydrate (4 ml/100 g, for mice
younger than P14; 2 ml/100 g, for older mice), and
sacrificed by intracardiac perfusion as described (Aracri
et al., 2013). Embryos at E14–E15 were quickly removed
from the perfused pregnant mouse (aged P40), and their
heads immersed in 4% paraformaldehyde in phosphate
buffer (PB), for 24 h at 4 C. Next, brains were removed
and stored for 5 to 10 days in the same fresh fixative. Both
embryonic and postnatal (until P14) brains were embed-
ded in 5% agarose. Serial coronal brain sections (50 lm
thick) were cut with a Leica VT1000S vibratome.
Primary antibodies
Anti-NKCC1: T4 monoclonal antibody, originated from
human colonic crypt (T84 cell) NKCC1, against the
carboxy-terminus M902 to S1212 (Developmental
Studies Hybridoma Bank; 1:100). Anti-KCC2: polyclonal,made in rabbit, against the N-terminal His-tag fusion
protein, corresponding to residues 932–1043 of rat
KCC2 (Millipore; diluted 1:600). Anti-VGAT (vesicular
GABA transporter): polyclonal, made in rabbit against
the synthetic peptide corresponding to the N-terminal
75–87 amino acids of the rat protein (Synaptic Systems;
1:800). Anti-VGLUT1 (vesicular glutamate
transporter type 1): polyclonal, made in rabbit against
Strep-TagR-fusion proteins containing the amino acid
residues 456–560 of the rat VGLUT1/BNPI (brain-
specific Na1-dependent inorganic phosphate
transporter; Synaptic Systems; 1:500). Anti-MAP2
(microtubule-associated protein 2): monoclonal, made in
mouse against the rat brain MAP2 (1:1000). Anti-
neurofilament H, non-phosphorylated: monoclonal,
made in mouse, (SMI32; Sternberger Monoclonals;
1:1000). Anti-GAD67 (glutamic acid decarboxylase type
1/67 kDa): polyclonal, made in goat against the
human recombinant glutamic acid decarboxylase type 1,
rhGAD1 (aa 2–97) derived from E. coli (R&D Systems;
1:300).Immunoperoxidase histochemistry for light and
electron microscopy
The immunoreaction was carried out as reported (Aracri
et al., 2010), except that a mild pretreatment with ethanol
(10%, 25%, 10% in phosphate buffered saline, PBS) was
applied to increase the immunoreagent penetration.
Reaction specificity was assessed by negative controls,
e.g. omission of primary antiserum. In these cases, no
specific staining was observed. Briefly, sections were
examined on a Leica DMRB microscope, and images
were acquired using a Leica DCF 480 camera coupled
to a personal computer. To generate Table 1, two inde-
pendent observers assessed the cotransporter distribu-
tion in different brain regions. At least 3 mice were
examined for each developmental stage. We analyzed
at least 3–4 sections for each cortical region (PFC, SS),
and 5–6 sections representative of the whole rostro-
caudal thalamic extension. Several images were acquired
per section. For ultrastructural analysis, sections were
osmicated and epoxy-embedded after completion of the
immunoenzymatic procedure. After polymerization, small
areas from cerebral cortex and TH were cut with a razor
blade and glued to blank resin blocks for sectioning with
a Reichert ultramicrotome. Ultrathin sections (50–70 nm)
collected on Cu/Rh grids were counterstained with lead
citrate, or left unstained, and examined with a Zeiss
LEO912AB electron microscope.Immunofluorescence histochemistry
Sections were permeabilized and blocked as described
for immunoperoxidase histochemistry. They were next
incubated for two nights in a mixture of one/two primary
antibodies, after staining with NeuroTraceTM (1:50,
Molecular Probes) and/or before staining with Hoechst
(Molecular Probes), as necessary for cytoarchitecture
analysis and cell counting. For NeuroTraceTM staining,
sections were treated as previously described (Aracri
et al., 2010). After washing the primary antibodies with
Table 1. Developmental distribution of NKCC1 and KCC2 in the forebrain of WT mouse
E14–E15 P0–P2 P7 P19–P21 P40–P60
KCC2 NKCC1 KCC2 KCC2 NKCC1 KCC2 NKCC1 KCC2
PFC +/ +++ + ++ ++ +++ ++ +++
SS +/ +++ ++ ++ ++ ++ ++ ++
TH ant + +++ +++ ++ +++ ++ +++ ++
TH me +/ ++ +++ ++ +/++ + ++ +
TH VB + +++ +++ +++ +++ ++ +++ ++
TH RT ++ +++ ++ + ++ +/++ ++ +/++
TH LG +++ +++ +++ +++ +++ +++ +++ +++
Semi-quantitative analysis of the distribution of Cl transporters in different brain regions, at different ages, based on immunohistochemical localization, using anti-NKCC1 or
anti-KCC2 antibodies, as indicated. The comparison between neonatal and P40 stages for KCC2 was also carried out by densitometric analysis, with analogous results (not
shown). PFC: prefrontal cortex; SS: somatosensory cortex; TH ant: anterior thalamic area; TH me: medial thalamus, i.e., intralaminar and midline nuclei; TH VB: thalamic
ventrobasal complex; TH RT: reticular thalamic nucleus; TH LG: lateral geniculate thalamic nuclei (comprising both dorsal and ventral lateral geniculate nuclei).
: negative; +/: scarce; +: moderately positive; ++: positive; +++: markedly positive.
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secondary fluorescent antibodies: indocarbocyanine
(Cy)2 (Jackson; 1:200), or CFTM488A-conjugated donkey
anti-rabbit IgG (Biotium; 1:200), Cy3-conjugated donkey
anti-mouse (1:200) or RedX-conjugated donkey anti-
goat (Jackson; 1:200), for 75 min at room temperature.
After rinsing, samples were mounted on coverslips
(sometimes after nuclear staining with Hoechst) with
PBS/glycerol (1:1 v/v) and inspected with a Leica TCS-
NT laser scanning confocal microscope, to visualize dou-
ble or triple fluorescent labeling.Colocalization and densitometric analysis
All confocal micrographs were collected at 40X with a
Leica SP2 laser scanning confocal microscope, and
analyzed with ImageJ. Identical parameters were used
to acquire images from cortical and TH areas, for the
colocalization analysis of NKCC1 with VGAT or
VGLUT1, as previously described (Aracri et al., 2013).
In brief, nonoverlapping pictures were acquired in at least
two different sections for neocortex or TH, so that double
immunolabeling was studied in 3 or 4 fields per region in
each animal. For two-color colocalization analysis, tissues
were excited at 488 and 568 nm. To avoid crosstalk, the
fluorescent signals of Cy2 (green) and Cy3 (red) were
detected sequentially. Colocalization of NKCC1 with
either VGAT or VGLUT1 was determined by generating
2D cytofluorograms (Bolte and Cordelie`res, 2006) by
Leica Confocal software, as shown in Fig. 2E, F. Genera-
tion of a binary mask of image data allowed to select in
each region certain intensity value pairs in the cytofluoro-
grams, which were labeled as white signals in the original
images, to represent merged antigen localization (Fig. 2C,
D). For densitometric analysis, cortical layers and TH
nuclei were identified with NeuroTraceTM and/or nuclear
counterstaining; at least three/four distinct images were
acquired to sample the different areas. For each animal,
the mean fluorescence intensity of each image was
divided by the number of neurons therein (counted with
ImageJ). The values thus obtained were averaged among
animals before plotting. For the densitometric analysis of
NKCC1, we selected fluorescent images with low back-
ground (as shown in Fig. 8). The degree of colocalization
of KCC2 or NKCC1 with different neuronal markers wascalculated by comparing the Manders’ coefficients, com-
puted with the JACoP plug-in of ImageJ software (Bolte
and Cordelie`res, 2006).Patch-clamp in brain slices
Mice were sacrificed after deep isoflurane anesthesia,
and brains extracted as reported (Aracri et al., 2013). Cor-
onal sections (300 lm thick) were cut from Fr2 PFC.
Experiments were performed at 33–34. EGABA was mea-
sured with the perforated patch method. The extracellular
solution contained (mM): 135 NaCl, 21 NaHCO3, 0.6
CaCl2, 3 KCl, 1.25 NaH2PO4, 1.8 MgSO4, 10 D-glucose,
aerated with 95% O2 and 5% CO2 (pH 7.4). Pipette con-
tained (mM): 140 K-Gluconate, 5 KCl, 1 MgCl2, 2.5
BAPTA, 10 HEPES, pH 7.25 (adjusted with KOH). Gram-
icidin (up to 20 mg/mL) was only added to the solution fill-
ing the pipette shank. Borosilicate (Science Products)
micropipettes (2–3 MX) were prepared with a P-97 Micro-
pipette Puller (Sutter). GABA was applied onto the cell
soma, by pressure ejection through a micropipette con-
nected to a Narishige IM-3 microinjector. The recording
apparatus was as described (Aracri et al., 2017). The
comparison of the action potential (AP) firing of pyramidal
neurons in mice expressing or not b2-V287L was carried
out in a separate set of experiments. The resting mem-
brane potential (Vrest) was measured in open circuit mode
soon after patch rupture. Spike-width was measured at
half-amplitude between AP threshold and peak. After-
hyperpolarization was calculated as the difference
between the most negative potential reached after repo-
larization and the AP threshold. Capacitance and series
resistance (up to 75%) were always compensated.
EGABA was determined by applying five consecutive 0.5
s voltage ramps from 80 mV to 20 mV (or 85 mV to
40 mV), in either presence or absence of GABA (100
mM). The background currents were subtracted from the
currents obtained in the presence of GABA. Holding
potential was 68 mV. Measurements were carried out
in the presence of extracellular TTX (0.5 mM), to block
voltage-gated Na+ currents, AP5 (50 mM) and CNQX
(10 mM), to block ionotropic glutamate receptors. No
leak subtraction procedure was ever applied. No
correction for junction potentials was applied to the
reported values of membrane potential. Data were
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ginPro 9.1 (OriginLab).Statistical analysis
Data are given as mean values ± st
andard error of the mean. The
number of experiments (n) is the
number of tested mice. Comparisons
between two independent
populations were carried out with
unpaired Student’s t-test, after
testing for data normality (with a
Kolmogorov–Smirnov test), and
variance homogeneity (with F-test).
In case of unequal variances, the
Welch’s correction was applied. All
determinations carried out in cells
from the same animal were
averaged, to avoid bias from nested
data (Aracri et al., 2017). In the fig-
ures, p values are indicated by *
(0.01 < p  0.05) or *** (p  0.01).
Unless otherwise indicated, detailed
statistics are given in the figure
legends.RESULTS
We first studied the overall pattern of
postnatal expression of NKCC1 and
KCC2 in WT mice, as no previous
systematic study is available for
mouse forebrain. Next, we
investigated the effect of b2-V287L
expression on the cotransporters’
amounts between the second and
the third postnatal week (i.e., the
critical stages of synaptogenesis),
and in adult mice. Because ADNFLE
is a sleep-related epilepsy with
frequent implication of the frontal
regions, we focus our study on both
PFC and TH, and use SS as the
classical reference cortex.Fig. 1. Topographical and cellular distribution of NKCC1 in developing WT neocortex and
thalamus (TH). Immunohistochemical localization of NKCC1 in PFC (A, C), SS (B, D) and TH (E, F)
of P0–P1 (A, B, E), and P19–P21 (C, D, F) mice. At both stages, NKCC1 was widely expressed in
neocortex and TH, and mainly localized in the apical dendrites of PFC and SS pyramidal cells
(arrowheads in A–D). Both in adulthood (G) and during development (H) NKCC1 was found in
neurons of both neocortex and TH (arrows in G, H). NKCC1 staining was particularly intense in
cortical apical dendrites (arrowheads in G), and in TH thin and thick axonal fibers, such as those of
internal capsule (IC). Representative pre-embedding immunoelectron microscopy (TH at P60 in I)
showed NKCC1 in the axons of myelinated fibers (f), in some glial processes (g) and in few small
synaptic terminals (t) contacting distal dendrites (d). CP, cortical plate; DLG, dorsal lateral
geniculate thalamic nucleus; MZ, marginal zone; I–VI, cortical layers; VLG, ventral lateral thalamic
geniculate nucleus; VPM, ventral posteromedial thalamic nucleus; VPL, ventral posterolateral
thalamic nucleus. Scale bars = 150 mm (A–F); 50 mm (G); 40 mm (H); 0.5 mm (I) .Distribution of NKCC1 in postnatal
cortex and TH of WT mice
Immunoperoxidase localization of
NKCC1 is shown in Fig. 1 for
neocortex and TH, at birth (P0–P1)
and P19–P21 (i.e., after completion
of synaptogenesis). For PFC and
SS, representative images are
respectively displayed in Fig. 1A, B
(P0–P1), and Fig. 1C, D (P19–P21).
NKCC1 was widely distributed in
neocortex since birth, with no clear
differences among layers. As for TH,
the NKCC1 immunoreactivity was
stronger and more stable in theanterior and posterior TH nuclei (i.e., the specific
nuclei). Examples at P0–P1 and P19–P21 are shown,
respectively, in Fig. 1E, F. In general, immunoreactivity
resulted stable in the different nuclei up to adult stages.
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generally found in both astrocytes (labeled for GFAP;
data not shown) and neurons (Hu¨bner et al., 2001; Yan
et al., 2001; Wang et al., 2002). In the neocortex, the
marked radial pattern of labeling indicates intense expres-
sion in the apical dendrites of pyramidal neurons at both
P19–P21 (Fig. 1C, D), and P60 (Fig. 1G), and fainter
labeling in cell bodies (Fig. 1G). Such pattern was
confirmed by confocal analysis, as indicated by the3representative images for SS shown in Fig. 2A (P2) and
2B (P60). In TH, strong immunoreactivity was also
observed in thin and thick fiber bundles (such as those
of internal capsule; Fig. 1H).
Ultrastructural analysis also revealed NKCC1+
synaptic boutons in adult neocortex and TH (an example
is given in Fig. 1I). The neurochemical nature of these
synaptic terminals was investigated by studying the
colocalization of NKCC1 with either VGAT (which labels
GABAergic terminals), or VGLUT1 (which labels the
majority of glutamatergic terminals; Graziano et al.,
2008). Representative images for the neocortex at P60
are shown in Fig. 2C (NKCC1/VGAT), and 2D (NKCC1/
VGLUT1). The degree of colocalization was estimated
by generating the corresponding 2D cytofluorograms, as
illustrated in Fig. 2E (NKCC1/VGAT), and 2F (NKCC1/
VGLUT1). The colocalization puncta are indicated as
white spots in Fig. 2C, D. In the mature neocortex, the
overlap between NKCC1 and VGAT was always weak.
In particular, the calculated M2 Manders’ coefficient for
Fig. 2C, E was 0.088. A higher degree of colocalization
was generally observed for NKCC1 and VGLUT1, particu-
larly in adult PFC (Fig. 2D, F). The calculated M2 coeffi-
cient for Fig. 2D, F was 0.8, indicating that 80% of the
VGLUT1+ synaptic terminals also displayed the NKCC1
signal. On the other hand, in TH nuclei, NKCC1+/VGAT
+ boutons were only transiently observed in the second
postnatal week (data not shown).Distribution of KCC2 in developing cortex and TH of
WT mice
The KCC2 distribution at different postnatal stages is
illustrated in Fig. 3. Clusters of a few KCC2 positive (+)
neurons were observed at P0–P1 in PFC layer V, and
more abundantly in SS, along with an intense
immunoreactivity in the marginal zone (Fig. 3A, B). The
overall KCC2 immunoreactivity was stronger at
P19–P21 (Fig. 3C, D). In TH, conspicuous labeling at
birth was detected throughout the neuropil, except forFig. 2. Double immunofluorescence of NKCC1 with KCC2, or with
synaptic markers, in WT neocortex. Representative images (A, B)
combining the NKCC1 (red) and KCC2 (green) signals, in SS. (A) At
P2, NKCC1 was found ubiquitously, especially in the neuropil; KCC2
only displayed punctate labeling in the somatodendritic compartment
of a fraction of neurons (arrows). (B) At P60, KCC2 and NKCC1 were
found in the apical dendrites, but their distribution scarcely over-
lapped. KCC2 was confined to the cell surface around neuronal cell
bodies (asterisks in B) and proximal dendrites (arrowheads in B); in
the same dendrites, NKCC1 showed a more diffuse, cytoplasmic
distribution. (C) Colocalization of NKCC1 (red) and VGAT (green), in
SS at P60. (D) Colocalization of NKCC1 (red) and VGLUT1 (green),
in PFC at P60. (E, F) 2D cytofluorograms showing the colocalization
puncta in the region of interest (enclosed by the yellow ellipsoid) for
NKCC1/VGAT (E) and NKCC1/VGLUT1 (F). These puncta are
reported as yellow/white signals in the merged immunolabeling
images (C, D), which represent high magnification details covering
about one third of the entire fields acquired for colocalization analysis.
At P60, very few terminals displayed both NKCC1 and VGAT signal
colocalization (C), whereas the degree of colocalization between
NKCC1 and VGLUT1 was much stronger (D). Scale bars = 20 mm.
(For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this article.)
Fig. 3. Topographical and cellular distribution of KCC2 in postnatal WT neocortex and thalamus
(TH). Immunohistochemical localization of KCC2 in P0–P1 (A, B, E) and P19–P21 (C, D, F) mice.
At birth, KCC2 was mainly confined to the neuronal cell bodies in PFC (A) and SS (B), and clusters
of KCC2+ neurons were mainly found in layer V (arrows in A, B). At P19–P21, KCC2 was
distributed throughout the neuropil in PFC (C) and SS (D). In TH nuclei, KCC2 was already present
at P0–P1 in the neuropil of all regions, except RT (E). At P21, KCC2 expression in TH slightly
decreased (F), and only a weak immunoreactivity was observed in the lateral and medial borders
of RT (F). The immunoperoxidase localization of KCC2 showed its presence only in the neuronal
cells and dendrites (G–J). At P2 in PFC, KCC2 was localized in multipolar neurons (arrows in G).
Subsequently, KCC2 became distributed in the neuropil and outlined cell membranes (arrows in
H), as shown also by immunoelectron microscopical localization (I), where it was exclusively
observed in cell bodies (CB) and proximal dendrites (D). In TH (J) KCC2 was mainly expressed by
the dendritic neuropil, even in the scarcely labeled RT. N, nucleus; CP, cortical plate; DLG, dorsal
lateral geniculate thalamic nucleus; MZ, marginal zone; I–VI, cortical layers; VLG, ventral lateral
thalamic geniculate nucleus; VPL, ventral posterolateral thalamic nucleus; VPM, ventral postero-
medial thalamic nucleus. Scale bars = 150 mm (A–F); 40 mm (G, H); 2 mm (I); 80 mm (J).
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displayed the highest labeling,
followed by the posterior group and
by the medial/intralaminar group.
Such a distribution pattern was
preserved at P19–P21 (Fig. 3E, F),
when RT was almost devoid of
KCC2 in its central region, whereas
the lateral and medial borders
displayed a fair labeling (Fig. 3F).
These results suggest that KCC2 is
expressed in TH earlier than in the
neocortex. This was confirmed by
KCC2 immunofluorescence at E14–
E15, which showed a faint KCC2
signal in frontal and parietal preplate
isocortices (Fig. 4A, B), but a more
conspicuous labeling in the ventral
(especially the ventral lateral
geniculate nucleus, VLG, Fig. 4D)
and dorsal TH (Fig. 4C, D).
Differently from NKCC1, KCC2
was only expressed in neurons and
dendrites (Fig. 3G–J), and its
distribution became increasingly
polarized during development. In the
neocortex, KCC2 was mainly
confined to the neuronal cell bodies,
during the first postnatal week
(Figs. 2A; 3A, B, G; 4E, G). At P19–
P21 (Fig. 3C, D), the transporter was
also found in the dendritic neuropil,
and outlined the cell membranes, as
can be better appreciated in Fig. 3H,
at a higher magnification. A similar
pattern was observed in the mature
cortex (Figs. 2B; 4F, H). In TH, such
distribution shift occurred before
birth (Fig. 4C, D), and postnatal
neurons showed maximal KCC2
expression in the neuropil (i.e.,
dendrites), even in the scarcely
labeled RT (Figs. 3J; 4I).
As for the neurochemical nature of
KCC2+ neurons in neocortex, during
the first postnatal week both
pyramidal neurons and GABAergic
GAD67+ neurons (Fig. 4E, G)
showed cytoplasmic immunoreactive
puncta, probably vesicles, which also
spread to proximal dendrites. After
P7, KCC2 mainly outlined the
membrane of pyramidal neurons
(labeled with SMI32; Fig. 4F),
whereas in GAD67+ structures (i.e.,
comprising neuronal cell bodies,
processes and puncta), KCC2 was
confined to the dendritic shafts
(Fig. 4H). A different pattern was
observed in TH. The GABAergic
neurons, which were mainly
Fig. 4. Localization of KCC2 in developing WT forebrain. A–D Topographical distribution of KCC2 in prenatal WT forebrain. Immunofluorescence
staining for KCC2 (green) in embryonic (E14–E15) cortical (A, B) and thalamic (C, D) tissues; nuclei were stained with Hoechst (blue). KCC2
immunoreactivity was faint in frontal (FC) and parietal (PC) pre-plate isocortex (A, B), but strong in the rostral (C) and caudal (D) thalamic anlage.
Double immunofluorescence in SS (E, G), PFC (F, H) and TH (I). Representative images are shown for KCC2 (green) and MAP2 (red) at P5 (E),
KCC2 (green) and SMI32 (red) at P40 (F), KCC2 (green) and GAD67 (red) at P0 and P40 (G–J). Around birth, KCC2 was mainly expressed in
neuronal cell bodies in the neocortex (arrows in E, G). The MAP2+ pyramidal neurons and the GAD67+ interneurons showed cytoplasmic stained
puncta, probably vesicles, spreading to proximal dendrites (E, G). In P40 neocortex, KCC2 was also found in dendrites (white arrowheads in F) and
outlined (arrow in F) pyramidal cell membranes (asterisks in F, H), whereas only a small fraction of the GAD67+ dendritic shafts (yellow
arrowheads in D) also displayed KCC2 labeling. In TH (I), KCC2 was found in the dendritic neuropil of all TH neurons, and in the medial border of
RT, where it displayed colocalization with GAD67 (yellow arrowheads in I). MZ, marginal zone; CP, cortical plate; SP, subplate; DT, dorsal
thalamus; TE thalamic eminence. Scale bars = 20 mm. Scale bars = 20 mm (A–D, H, I); 10 mm (E, G); 50 mm (F). (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article.)
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expression. An exception was constituted by the
dendrites of the GAD67+ cells located on the medial
border of RT (Fig. 4I). KCC2 was however intensely
expressed by the dendritic neuropil of all TH neurons
(Figs. 3E, F, J; 4I).
A semi-quantitative summary of the distribution of
NKCC1 and KCC2 in PFC and TH, as obtained by
immunohistochemistry at the relevant ages, is reported
in Table 1.The b2-V287L nAChR subunit altered the timing of
KCC2 expression
To define more rigorously the spatiotemporal distribution
of KCC2 at the critical postnatal stages as well as the
ratio between KCC2 and NKCC1, a densitometric
analysis was performed on confocal sections from mice
expressing the transgene (b2-V287L) and the control
littermates (CTRL). Because the maturation of synaptic
circuits is accompanied by an increase in nAChRFig. 5. Effect of b2-V287L on KCC2 expression in neocortex during postnata
with NeuroTraceTM (red; NT) and Hoechst (blue), in PFC layer V of CTRL
corresponding densitometric analyses are summarized in the bar graphs for la
PFC (respectively C, G, K), and SS (respectively D, H, L). Bars give average fl
KCC2 expression in PFC layer V (C) was significantly lower in b2-V287L (0.3
The opposite was observed at P60, when KCC2 significantly increased in la
with t-test; n= 8) (K). No statistical difference between genotypes was obse
references to color in this figure legend, the reader is referred to the web vesubunit expression between the second and the third
postnatal weeks (Molas and Dierssen, 2014), we com-
pared P8, P21 and adult (P60) tissue. Sections were
labeled for KCC2 and NeuroTraceTM, or Hoechst 33258.
The intensity of KCC2 fluorescence was divided by the
number of cells identified with either marker.
Fig. 5 shows the results obtained in the neocortex at
P8 (Fig. 5A–D), P21 (Fig. 5E–H) and P60 (Fig. 5I–L).
The time course of KCC2 expression in the transgenic
strain was consistent with the one observed in WT
mice. For example, in CTRL, the densitometric values in
PFC layer V increased by more than 60% between P8
(0.49 ± 0.014; n= 3) and P60 (0.81 ± 0.05; n= 8;
p< 0.01 with unpaired t-test; DF = 9), confirming the
progressive increase of KCC2 amount after birth (cf.
Table 1). The main differences between b2-V287L and
CTRL mice were observed in PFC layer V, where
smaller amounts of KCC2 were observed at P8 in b2-
V287L mice (Fig. 5C). Such difference disappeared by
P21 (Fig. 5G), and the effect was reversed at
P60, when KCC2 expression was significantly higher inl development. Immunofluorescence for KCC2 (green) counterstained
(A, E, I) and b2-V287L (B, F, J) mice, at the indicated ages. The
yers II/III and V from P8 (n= 3), P21 (n= 3) and P60 (n= 8) mice in
uorescence intensity values divided by the number of neurons. At P8,
7 ± 0.004 vs 0.49 ± 0.014 in CTRL; p< 0.01, with t-test; n= 3) (C).
yer V of b2-V287L (0.98 ± 0.06, vs. 0.81 ± 0.05 in CTRL; p< 0.05,
rved in SS (with t-test). Scale bar = 20 mm. (For interpretation of the
rsion of this article.)
100 A. Amadeo et al. / Neuroscience 386 (2018) 91–107b2-V287L mice (Fig. 5K). In particular, in layer V, the ratio
between the mean KCC2 fluorescence per cell in CTRL
and b2-V287L decreased from 1.32 (P8) to 0.83
(P60). At the same ages, no differences were found in
the KCC2 amounts in SS (Fig. 5D, H, L).
To test whether the higher KCC2 amount observed in
the PFC of adult b2-V287L mice could be partly ascribed
to changes in the GABAergic neuronal populations, we
analyzed the colocalization of KCC2 with GAD67. In
PFC layer V, at P60 we observed the typical KCC2+
outlines around the cell bodies of pyramidal neurons
(Fig. 4F), in WT (Fig. 4H), CTRL (Fig. 6A-A0) and b2-
V287L (Fig. 6B-B0). In GAD67+ neurons, KCC2
expression was generally scarce (Fig. 4H, 6A-A0),
although some colocalization was observed in b2-V287L
(Fig. 6B-B0). Hence, the higher KCC2 amount observed
in the PFC of adult b2-V287L mice could partly depend
on a different expression in GABAergic neuronal
subpopulation. To determine the contribution of
GABAergic cells to the total KCC2 increment weFig. 6. Colocalization of KCC2 and GAD67 in PFC layer V of mice express
Double immunofluorescence images in PFC layer V at P60, combining KCC2
(red) localizations with nuclear staining with Hoechst (blue), for CTRL (A) an
corresponding single labeling for KCC2 is shown in (A0) for CTRL and (B0)
represent the results obtained in 3 mice for each genotype. In CTRL, GAD67+
weak KCC2+ staining of somatic neuronal membranes (white arrowheads),
outlines of pyramidal neurons’ somata (yellow arrowheads). In b2-V287L, t
activity pointed out somatic outlines also on some GAD67+ neurons (asteri
= 20 mm. (For interpretation of the references to color in this figure legend, the
the web version of this article.)quantified the overall colocalization of KCC2 and
GAD67 (i.e., comprising neuronal cell bodies, processes
and puncta). The degree of overlap was defined by M1
and M2 Manders’ coefficients, and was not significantly
different between CTRL and b2-V287L mice. At P60, in
PFC layer V, M1 (the fraction of colocalization on the
total KCC2+ signal) was 0.17139 ± 0.00565 in CTRL,
and 0.17008 ± 0.00743 in b2-V287L (p= 0.895, with
unpaired t-test; n= 3); M2 (the fraction of colocalization
on the total GAD67+ signal) was 0.36657 ± 0.00933 in
CTRL, and 0.35333 ± 0.01154 in b2-V287L (p= 0.423,
with unpaired t-test; n= 3).
In TH, our densitometric analysis was focused on RT
and on the main somatosensory relay nucleus VB. Once
again, this analysis was consistent with the pattern
observed in WT (Table 1). For example, in CTRL, the
mean fluorescence intensity per cell in RT was
0.85 ± 0.07, at P8 (n= 3), and 1.7 ± 0.04, at P60
(n= 3; p< 0.001, with unpaired t-test; DF = 4).
Representative images at P60 are shown in Fig. 7A, B. Ining or not b2-V287L.
(green) and GAD67
d b2-V287L (B). The
for b2-V287L. Data
neurons showed a
but marked KCC2+
he KCC2 immunore-
sks in B0). Scale bar
reader is referred toboth nuclei, no significant differences
were observed between genotypes at
early postnatal stages (not shown).
However, at P60, the average KCC2
amount decreased in RT by 20% in
b2-V287L mice, compared to CTRL
(Fig. 7C). Because in RT the KCC2+
signal was always confined to the
GAD67+ dendritic neuropil (Fig. 4I),
no analysis of overlap by Manders’
coefficients was performed.b2-V287L did not change NKCC1
expression
Because [Cl]i is regulated by both
KCC2 and NKCC1, our
densitometric analysis was extended
to NKCC1, in PFC and TH, at P8
and P60 (Fig. 8), i.e., the regions
and ages displaying altered KCC2
amounts in b2-V287L mice. To this
purpose, we used the T4 antibody
against NKCC1, which was also
employed for the analysis of
developing WT forebrain (Figs. 1
and 2). This antibody was previously
used in rodent neocortex,
hippocampus and brain stem (Yan
et al., 2001; Marty et al., 2002; Ge
et al., 2006; Liu and Wong-Riley,
2012) and presents a very good
specificity (Chen et al., 2005). Repre-
sentative images are shown in
Fig. 8A, C, E, G. In PFC, NKCC1
expression presented no significant
genotype-dependent alteration
at P8 (Fig. 8B) and P60 (Fig. 8D).
Similar results were obtained in TH
(Fig. 8F, H).
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layer V
The immunofluorescence results show that the retarded
expression of KCC2 in PFC layer V of b2-V287L mice
was not accompanied by major changes of NKCC1. We
thus hypothesized that a lower ratio between the
amounts of KCC2 and NKCC1 could be associated with
a delayed GABAergic switch. This was tested by
measuring EGABA in pyramidal cells of PFC layer V, in
brain slices from P8-P9 and adult mice (older than P40).
Layer V is prominent in the premotor Fr2 PFC, and
presents large pyramidal neurons that are well
recognizable since early postnatal stages. The
morphological and electrophysiological properties of
these neurons were previously described in detail
(Aracri et al., 2010, 2013, 2015). In brief, they display reg-
ular spiking with frequencies between 10 and 30 Hz and
moderate adaptation, in the presence of depolarizing
stimuli of 150 to 300 pA. The electrophysiological features
of these cells are reported in Table 2, for a representative
sample of P37-P50 mice bearing or not b2-V287L. No sta-
tistical difference was observed between CTRL and b2-
V287L in Vrest, spike width, the ratio between the fourth
and the first spike intervals, and after-hyperpolarization
(with unpaired t-test). Similar values were measured in
the second postnatal week (data not shown). In such
pyramidal cells, we measured EGABA with the perforated
patch method, to avoid perturbing [Cl]i. Representative
GABAergic current traces obtained by applying
voltage ramps from 85 to 40 mV (or 80 to 20 mV,
at P8–P9) are displayed in Fig. 9A, for the indicated
experimental groups. During brain maturation, EGABA pro-
gressively hyperpolarized, shifting from 48.6 ± 2.03 mV
at P8–P9 (15 cells were sampled from 5 mice), to 58 ±
1.7 mV in adult mice (31 cells, from 10 mice; p< 0.01,
compared with the younger mice; unpaired t-test). A sim-
ilar pattern was observed in adult b2-V287L, where EGABA
was 56 ± 2.5 mV (13 cells, from 5 mice; not statistically
different from CTRL, with unpaired t-test). However, at
P8–P9, in b2-V287L mice EGABA was more depolarized
than in the controls (42 ± 1.65 mV; 11 cells from
4 mice; p< 0.05, compared with CTRL, with unpairedFig. 7. Effect of b2-V287L on thalamic expression of KCC2 at P60.
Representative immunofluorescence images for KCC2 (green) coun-
terstained with Hoechst (blue), in TH nuclei of CTRL (A) and b2-
V287L (B) mice. The corresponding densitometric analyses are
shown in the bar graphs (C), for RT and VB nuclei, as indicated. Data
are given as mean fluorescence intensity values divided by the
number of neurons. Mice bearing b2-V287L displayed a decreased
KCC2 amount in RT (1.38 ± 0.07, vs. 1.77 ± 0.04 in CTRL; p<
0.01; DF = 4; unpaired two-sample t-test with equal variance
assumed; n= 3). No significant difference was observed in VB (p
= 0.777; DF = 4; unpaired two-sample t-test with equal variance
assumed; n= 3). Scale bar = 20 mm. (For interpretation of the
references to color in this figure legend, the reader is referred to the
web version of this article.)
Fig. 8. Effect of b2-V287L on NKCC1 expression in developing PFC
and TH. Representative images of immunofluorescence for NKCC1
(red) counterstained with Hoechst (blue), in PFC layer V (A, C) and
TH nuclei (E, G) of CTRL and b2-V287L mice, at P8 (A, E) and at P60
(C, G). The corresponding densitometric analyses are summarized in
the bar graphs for layers II–III and V from P8 and P60 mice in PFC
(respectively B and D) and in thalamic nuclei RT and VB (F, H), at P8
(B, F) and P60 (D, H). Data are expressed as mean fluorescence
intensity divided by the number of neurons. At P8 (n= 3) and P60 (n
= 3), no significant differences were observed in NKCC1 expression
between CTRL and b2-V287L, in either PFC or TH. For example, in
RT at P60, the mean fluorescence per cell was 0.73 ± 0.046 in
CTRL, and 1.1 ± 0.35 in b2-V287L (p= 0.396; DF = 2.07; unpaired
t-test, assuming unequal variances). In VB, the corresponding values
were 0.96 ± 0.1 (CTRL) and 1.13 ± 0.09 (b2-V287; p= 0.27; DF
= 4; unpaired t-test, assuming equal variances). Scale bar = 20 mm.
(For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this article.)
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that, in PFC layer V, the time course of EGABA hyperpolar-
ization was delayed in b2-V287L mice, in agreement with
our immunofluorescence results.DISCUSSION
We have analyzed the distribution of NKCC1 and KCC2 in
the murine neocortex and TH, at different developmental
stages. The study was carried out on both WT and a
transgenic murine model of ADNFLE. The main finding
was that mice carrying the mutant nAChR subunit
b2-V287L displayed a delayed surface expression of
KCC2 (but not NKCC1) in PFC layer V, during the first
postnatal weeks. This led to a transient decrease in the
ratio between KCC2 and NKCC1, which was
accompanied by a retarded GABAergic switch.
Moreover, expression of b2-V287L was also correlated
to changes in KCC2 expression in adult PFC and RT
thalamic nucleus.Regional distribution of NKCC1 and KCC2 in
postnatal neocortex
Previous work in rodents revealed a complex timing and
cellular distribution of NKCC1 expression, in different
brain regions. Nonetheless, our data agree with the
frequent observation that the NKCC1 messenger and
protein reach the highest amounts in the neocortex
between P7 and P21 (Plotkin et al., 1997; Clayton et al.,
1998; Yan et al., 2001; Wang et al., 2002; Dzhala et al.,
2005). Whether these levels of expression are retained
in the adult is more controversial, as results depend on
species as well as on the used antibodies and probes
(Plotkin et al., 1997; Clayton et al., 1998; Hu¨bner et al.,
2001; Yan et al., 2001; Wang et al., 2002; Dzhala et al.,
2005). Our results in both WT and transgenic mice sug-
gest that the surface amount of NKCC1 remains overall
stable in the mature PFC.
As for KCC2, at birth it was specifically localized in the
marginal zone and infragranular layers. Its expression
increased thereafter, and reached the adult distribution
by the third postnatal week, in both WT and transgenic
mice. This process paralleled the GABAergic switch,
which in neocortex and hippocampus is delayed
compared to the subcortical structures (Fiumelli and
Woodin, 2007; Kova´cs et al., 2014). Once again, our
results broadly agree with previous results in mouse
showing that KCC2 increases in postnatal stages,
although regional exceptions are observed (Wang et al.,
2002; Kova´cs et al., 2014; Markkanen et al., 2014). They
also agree with several non-systematic determinations in
rat (Lacoh et al., 2013), and human tissue (Hyde et al.,
2011). Moreover, we found KCC2 expression to be more
precocious in SS. Together with other observations on
more specific markers (Hyde et al., 2011; Aracri et al.,
2013), these results support the notion that PFC matures
more slowly than other brain regions, which could make it
more liable to develop pathologies related to network mat-
uration, such as certain forms of epilepsy and schizophre-
nia (Hyde et al., 2011; Lacoh et al., 2013; Kaila et al.,
2014a; Kova´cs et al., 2014).Cotransporters’ distribution in thalamic nuclei
Minor differences were observed in the postnatal amounts
of NKCC1 at the tested stages, in both WT and transgenic
Table 2. Expression of b2-V287L did not alter Vrest and the firing properties of pyramidal cells in PFC layer V
Vrest
(mV)
Spike width
(ms)
4thspike interval/1stspike interval AHP
mV
N
CTRL 69.4 ± 0.63 1.52 ± 0.08 1.8 ± 0.1 9.3 ± 0.49 11
b2-V287L 68.9 ± 0.52 1.51 ± 0.05 1.9 ± 0.09 –9.3 ± 0.59 9
Mice were aged P37–P50. The ratios between the fourth and the first spike interval were calculated in the presence of a 200 pA stimulation, and average firing frequency of
15 Hz. No statistical difference was observed between mice expressing or not b2-V287L (with unpaired t-test). AHP: after-hyperpolarization.
Fig. 9. The effect of b2-V287L on the GABAergic switch. The time-
course of EGABA was followed by perforated-patch experiments.
Layer V pyramidal neurons were studied at P8–P9 or adult stages.
(A) Representative current traces (averages of 5 trials), elicited by
voltage ramps (500 ms duration), in b2-V287L or CTRL mice, as
indicated. The ramps between 85 and 40 mV are relative to adult
mice. The ramp between 80 and 20 mV is relative to a P8 mouse.
The background current was always subtracted to the current
measured in the presence of GABA. (B) Average EGABA values at
the indicated stages, in CTRL and b2-V287L mice. Detailed statistics
are given in the main text.
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WT mice, KCC2 was found in VLG and RT as early as
E14–E15, and conspicuous expression was observed atbirth in all TH nuclei (Table 1). Its amount remained
relatively stable thereafter, except in RT, where a
transient KCC2 decrease was observed at the end of
the first postnatal weeks, in both WT (Table 1) and
transgenic mice (see text). Although no other systematic
comparison of the KCC2 distribution in mouse TH is
available, previous evidence also points to early KCC2
expression in TH nuclei (Hu¨bner et al., 2001; Li et al.,
2002; Wang et al., 2002; Stein et al., 2004; Horn et al.,
2010; Markkanen et al., 2014). This likely reflects the
quicker time course of thalamic circuit wiring, which is
complete by P14–P15 (Amadeo et al., 2001). In fact, [Cl]i
is essentially stable by the second postnatal week in rat
VB (Glykys et al., 2009). More specifically, the so-called
relay nuclei (comprising the anterior region), show a rapid
maturation that reflects the early establishment of the
connections implicated in sensory map topography
(Lopez-Bendito and Molna´r, 2003). By contrast, the adult
RT is characterized by a weaker KCC2 immunolabeling
compared with the more caudal adjacent relay nuclei
(Bartho´ et al., 2004). Our results show that such differ-
ence is not precocious, but is caused by a postnatal
decrease of KCC2 in RT. Although little is known about
the development of synaptic connections in RT
(Amadeo et al., 2001; Nagaeva and Akhamadeev, 2006;
Hou et al., 2016), we hypothesize that proper synaptoge-
nesis here requires KCC2 amounts similar to those pre-
sent in other TH nuclei. Subsequently, KCC2 would
stabilize at lower levels in the adult RT, where EGABA is
more depolarized than in relay cells (Ulrich and
Huguenard, 1997; Bartho´ et al., 2004; Sun et al., 2013),
and the reciprocal GABAergic connections lead to excita-
tory effects (Sun et al., 2012).Cellular distribution of NKCC1 and KCC2 in
neocortex and thalamus
In neocortex and TH, our confocal and ultrastructural
analysis showed wide expression of NKCC1 in neurons,
axons, synaptic terminals and astrocytes in agreement
with previous results (Hu¨bner et al., 2001; Yan et al.,
2001; Wang et al., 2002). NKCC1 was mainly found in
the apical dendrites of cortical pyramidal neurons and in
myelinated fiber bundles in TH, suggesting that specific
mechanisms of NKCC1 regulation operate in distinct neu-
ronal compartments (Hu¨bner et al., 2001; Yan et al.,
2001). Moreover, electron and confocal microscopy
revealed NKCC1 in synaptic terminals. In particular,
NKCC1 was found in glutamatergic (VGLUT1+) termi-
nals, especially in adult PFC. In contrast, NKCC1 was
rarely found in GABAergic (VGAT+) terminals, except
in developing TH. The study of NKCC1 expression and
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Physiological evidence indicates that presynaptic NKCC1
can stimulate (Bos et al., 2011) as well as inhibit (Shen
et al., 2013) neurotransmitter release, making it difficult
to provide a general interpretation of our results. In imma-
ture rat spinal cord, NKCC1 activity enhances transmitter
release from afferent fibers by favoring a GABA-
dependent presynaptic depolarization (Bos et al., 2011).
We can hypothesize that a similar mechanism is operant
in the developing TH, thus facilitating the usual depolariz-
ing role of GABA in early stages. In contrast, NKCC1 has
been found to inhibit glutamate release in photoreceptors
(Shen et al., 2013), a mechanism worth further investiga-
tion in the PFC VGLUT1+ terminals.
At variance with NKCC1, the cellular distribution of
KCC2 was different in cortical and TH neurons. In
neonatal neocortex, KCC2 was mainly localized in cell
bodies of pyramidal and GABAergic neurons. During the
first postnatal week, KCC2 shifted to cell membranes
and dendrites, even though a significant amount of the
transporter was retained on the surface of pyramidal
neurons’ somata. This presumably reflects the high
density of GABAergic synapses around pyramidal cell
bodies. Such a pattern is broadly similar to the one
observed in other species (Stein et al., 2004; Dzhala
et al., 2005; Li et al., 2007; Hyde et al., 2011; Kova´cs
et al., 2014). On the contrary, the KCC2 immunoreactivity
of TH nuclei at birth was much closer to the adult’s; this is
consistent with the concept that, in rodents, KCC2
appears earlier in the TH anlage than in neocortex. The
KCC2+ outlines observed around pyramidal cell bodies
were absent or discontinuous in cortical and TH GABAer-
gic cells, where KCC2 immunoreactivity was mainly con-
fined to the dendrites. We attribute such difference to the
relatively low average density of reciprocal GABAergic
terminals among inhibitory interneurons in neocortex
and TH (Pi et al., 2013; Hou et al., 2016; Aracri et al.,
2017).The effect of b2-V287L on cotransporters’ amounts
and the GABAergic switch
In rodent neocortex, the nAChR subunit expression peaks
in the second postnatal week, and recent lines of
evidence indicate that synaptic maturation is regulated
by both a7- and b2-containing nAChRs (Molas and
Dierssen, 2014). Because the maximal nAChR expres-
sion is concomitant with the GABAergic switch, we stud-
ied if b2-V287L affected the Cl cotransporters.
Between the first and the second postnatal week, the
increase of KCC2 expression was delayed by b2-V287L,
in PFC layer V. Since the effect was not accompanied
by any alteration of NKCC1, we expected mice express-
ing b2-V287L to also display a more depolarized EGABA,
around P8. In fact, the GABAergic switch was delayed
in these animals. Our data suggest that a regulatory inter-
action occurs between KCC2 and heteromeric nAChRs
during synaptogenesis. The specific effect observed in
layer V is consistent with the fact that, in this layer, the
action of ACh is dominated by b2-containing nAChRs
(Aracri et al., 2013; Poorthuis et al., 2013). Previous workalso showed that expression of b2-V287L does not
change the amount of heteromeric nAChRs on the
plasma membrane (Manfredi et al., 2009). Therefore,
we attribute the action of the mutant subunit to the func-
tional alterations it produces on nAChRs, rather than to
an overall alteration of nAChR expression. Both b2-
containing nAChRs (Lozada et al., 2012; Molas and
Dierssen, 2014) and KCC2 (Li et al., 2007; Fiumelli
et al., 2013) regulate the formation and maturation of den-
dritic spines by mechanisms that are thought to involve
the actin cytoskeleton. Because activating nAChRs leads
to both membrane depolarization and Ca2+ influx,
hyperfunctional mutant receptors containing b2-V287L
(De Fusco et al., 2000) could alter KCC2 expression by
interfering with calcium signals. An alternative explanation
is based on the finding that b2-V287L, as well as other
ADNFLE mutations, favors the assembly of the high-
affinity (a4)2(b2)3 nAChR stoichiometry with respect to
the low affinity (a4)3(b2)2 subtype (Son et al., 2009).
One can hypothesize that the altered proportion of stoi-
chiometric forms, besides altering the receptor’s response
to the agonist, could modify the nAChR binding to some
regulatory element of the dendritic spine machinery, or
possibly to KCC2 itself.
Irrespective of the molecular mechanism, the effect
we observed around P8 was transient. At P60, the
amount of KCC2 in PFC layer V was higher in b2-
V287L mice, even though EGABA was similar in adult
mice carrying or not the transgene. Because layer V is
highly susceptible to develop seizures (Telfeian and
Connors, 1998), we hypothesize that the steady-state
increase of KCC2 in the mutant is a compensatory mech-
anism. A higher local Cl turnover would be necessary to
sustain inhibition in an overactive network, and prevent a
significant alteration of the steady state Cl levels. This
explanation would be consistent with the observation that
in chronic epileptic conditions (Pathak et al., 2007;
Karlo´cai et al., 2016), or peritumoral tissue (Conti et al.,
2011), the KCC2 amounts usually increase, which points
to a long-term compensation of hyperexcitability. In fact,
deleting KCC2 in mice facilitates epileptiform activity
(Woo et al., 2002; Tornberg et al., 2005), and mutations
impairing KCC2 are linked to human epilepsy (Kahle
et al., 2014; Puskarjov et al., 2014). It must be however
recalled that the physiological meaning of the changes
of KCC2 expression observed in epileptic networks is
complex and still controversial, as the observed effects
depend on the pathophysiological context and the studied
region. For example, in temporal lobe, acutely induced
epileptiform activity (Rivera et al., 2002; Wake et al.,
2007; Puskarjov et al., 2012), and the induction of status
epilepticus (Pathak et al., 2007; Li et al., 2008;
Barmashenko et al., 2011) produce a chronic decrease
of KCC2 surface expression, which is attributed to the
action of higher calpain levels (Kaila et al., 2014b).
As for the thalamic effects of mutant nAChRs, mice
bearing b2-V287L displayed a lower KCC2 level in the
mature RT nucleus. Differently from the GABAergic cells
in adult PFC, in which the somatic expression of
nAChRs is population-specific (Aracri et al., 2017), the
GABAergic RT neurons in mice express a relatively high
A. Amadeo et al. / Neuroscience 386 (2018) 91–107 105density of postsynaptic a4b2 nAChRs. These can effec-
tively trigger action potentials, when the cholinergic affer-
ents are activated (Sun et al., 2013). Therefore,
hyperfunctional mutant nAChRs could over-stimulate RT
neurons and boost calcium signaling therein. As dis-
cussed earlier, this could favor a calpain-dependent
KCC2 downregulation. Such a mechanism could also be
facilitated by the typical propensity of RT cells to enter into
burst-like firing states (Fogerson and Huguenard, 2016).
CONCLUSION
The retardation of the GABAergic switch we observed in
the PFC of mice carrying b2-V287L suggests that the
pathogenetic mechanism in ADNFLE comprises
physiological alterations during synaptogenesis that are
likely to depend on the integrity of GABAergic signaling.
In the adult, complex alterations of KCC2 expression
were observed in the PFC and RT nucleus of mice
expressing the transgene. Understanding the precise
functional meaning of these alterations will require
deeper studies on the thalamocortical excitability of
these mice. Nonetheless, the fact that no such alteration
was observed in SS cortex and the other TH nuclei is
consistent with the hypothesis that the effect of b2-
V287L is specifically related to frontal hyperexcitability
during sleep.
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